Uwell Biopharma, Inc. (TPEX:7902)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.15
-2.50 (-5.25%)
At close: Apr 17, 2026
Market Cap9.03B
Revenue (ttm)450.00K
Net Income-54.86M
EPS-0.47
Shares Out200.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume480,295
Average Volume373,945
Open48.30
Previous Close47.65
Day's Range43.90 - 48.35
52-Week Range7.80 - 51.50
Betan/a
RSI62.31
Earnings Daten/a

About Uwell Biopharma

Uwell Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel cancer immunotherapeutic in Taiwan. The company provides chimeric antigen receptor T-cell (CAR-T) therapy platforms, lentiviral vector production, and related services. The company was founded in 2020 and is based in New Taipei City, Taiwan. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2020
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 7902
Full Company Profile

Financial Performance

Financial Statements